Clynes M - Search Results

1

Clynes M, Corbett A, Overbaugh J. Clynes M, et al. Nat Rev Cancer. 2019 Sep;19(9):489-493. doi: 10.1038/s41568-019-0173-1. Epub 2019 Jul 29. Nat Rev Cancer. 2019. PMID: 31358894

2

Membrane transport proteins in human melanoma: associations with tumour aggressiveness and metastasis.

Walsh N, Kennedy S, Larkin AM, Tryfonopoulos D, Eustace AJ, Mahgoub T, Conway C, Oglesby I, Collins D, Ballot J, Ooi WS, Gullo G, Clynes M, Crown J, O'Driscoll L. Walsh N, et al. Among authors: clynes m. Br J Cancer. 2010 Mar 30;102(7):1157-62. doi: 10.1038/sj.bjc.6605590. Epub 2010 Mar 16. Br J Cancer. 2010. PMID: 20234362 Free PMC article.

3

PP2A inhibition overcomes acquired resistance to HER2 targeted therapy.

McDermott MS, Browne BC, Conlon NT, O'Brien NA, Slamon DJ, Henry M, Meleady P, Clynes M, Dowling P, Crown J, O'Donovan N. McDermott MS, et al. Among authors: clynes m. Mol Cancer. 2014 Jun 24;13:157. doi: 10.1186/1476-4598-13-157. Mol Cancer. 2014. PMID: 24958351 Free PMC article.

4

Correction: PP2A inhibition overcomes acquired resistance to HER2 targeted therapy.

McDermott MSJ, Browne BC, Conlon NT, O'Brien NA, Slamon DJ, Henry M, Meleady P, Clynes M, Dowling P, Crown J, O'Donovan N. McDermott MSJ, et al. Among authors: clynes m. Mol Cancer. 2023 Oct 30;22(1):175. doi: 10.1186/s12943-023-01890-z. Mol Cancer. 2023. PMID: 37915024 Free PMC article. No abstract available.

5

Lack of prognostic significance of survivin, survivin-deltaEx3, survivin-2B, galectin-3, bag-1, bax-alpha and MRP-1 mRNAs in breast cancer.

O'Driscoll L, Linehan R, M Kennedy S, Cronin D, Purcell R, Glynn S, W McDermott E, D Hill A, J O'Higgins N, Parkinson M, Clynes M. O'Driscoll L, et al. Among authors: m kennedy s, clynes m. Cancer Lett. 2003 Nov 25;201(2):225-36. doi: 10.1016/s0304-3835(03)00518-4. Cancer Lett. 2003. PMID: 14607338

6

Enhanced in vitro invasiveness and drug resistance with altered gene expression patterns in a human lung carcinoma cell line after pulse selection with anticancer drugs.

Liang Y, O'Driscoll L, McDonnell S, Doolan P, Oglesby I, Duffy K, O'Connor R, Clynes M. Liang Y, et al. Among authors: clynes m. Int J Cancer. 2004 Sep 10;111(4):484-93. doi: 10.1002/ijc.20230. Int J Cancer. 2004. PMID: 15239124 Free article.

7

Investigation of MRP-1 protein and MDR-1 P-glycoprotein expression in invasive breast cancer: a prognostic study.

Larkin A, O'Driscoll L, Kennedy S, Purcell R, Moran E, Crown J, Parkinson M, Clynes M. Larkin A, et al. Among authors: clynes m. Int J Cancer. 2004 Nov 1;112(2):286-94. doi: 10.1002/ijc.20369. Int J Cancer. 2004. PMID: 15352042 Free article.

8

A new superinvasive in vitro phenotype induced by selection of human breast carcinoma cells with the chemotherapeutic drugs paclitaxel and doxorubicin.

Glynn SA, Gammell P, Heenan M, O'Connor R, Liang Y, Keenan J, Clynes M. Glynn SA, et al. Among authors: clynes m. Br J Cancer. 2004 Nov 15;91(10):1800-7. doi: 10.1038/sj.bjc.6602221. Br J Cancer. 2004. PMID: 15505620 Free PMC article.

9

The 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors, simvastatin, lovastatin and mevastatin inhibit proliferation and invasion of melanoma cells.

Glynn SA, O'Sullivan D, Eustace AJ, Clynes M, O'Donovan N. Glynn SA, et al. Among authors: clynes m. BMC Cancer. 2008 Jan 16;8:9. doi: 10.1186/1471-2407-8-9. BMC Cancer. 2008. PMID: 18199328 Free PMC article.

10

CYP1B1 expression is induced by docetaxel: effect on cell viability and drug resistance.

Martinez VG, O'Connor R, Liang Y, Clynes M. Martinez VG, et al. Among authors: clynes m. Br J Cancer. 2008 Feb 12;98(3):564-70. doi: 10.1038/sj.bjc.6604195. Epub 2008 Jan 22. Br J Cancer. 2008. PMID: 18212750 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

322 results

Search Page